Develops hybrid prescription drugs that combine medication with app-based digital therapeutics to improve outcomes for neurological conditions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Remepy develops “Hybrid Drugs” that combine traditional pharmaceuticals with clinically validated, app-delivered digital protocols into a single, regulated prescription. This approach integrates medication and personalized digital therapeutics to enhance motor, cognitive, and mental function, aiming to deliver superior outcomes for conditions such as Parkinson’s disease.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Remepy Management Team
Investors
Firstime Venture Capital
NFX
PsyMed Ventures
Supernode Ventures
Vine Ventures
Remepy Valuations & Financials
View real-time NPM data on Remepy stock including daily Remepy stock price estimates, valuation history, and historical share price information. Access Remepy financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Remepy pricing across six independent market signals. Looking for private company due diligence data sources on Remepy? Get in touch to learn more.
Similar Companies
like Remepy
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Treadwell Therapeutics
Healthcare & Life Sciences
Provides software solutions and tools to help businesses track, manage and improve their ESG performance and sustainability initiatives.
Devialet
An audio technology company that develops high-fidelity sound systems, including amplifiers, speakers, earbuds, and soundbars.
Sermonix Pharmaceuticals
Healthcare & Life Sciences
Biotech company developing targeted treatments for breast and ovarian cancers, specializing in innovative hormone receptor therapies.
Strata Oncology
Healthcare & Life Sciences
Provides precision medicine solutions through genomic profiling to match cancer patients with targeted therapies for improved treatment outcomes.
Robotic Skies
Provides global maintenance, repair, and inspection services for commercial drone fleets through a network of certified service centers.
HyperPlay
Media & Entertainment
Gaming platform that unifies multiple game stores and enables cross-platform play with integrated Web3 wallet functionality.
AI Medical Service
Develops AI-powered diagnostic solutions for endoscopic imaging, specializing in early detection of gastrointestinal cancers.
FAQ
We have answers
Remepy stock does not trade on public stock exchanges. Remepy stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Remepy stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Remepy Stock does not trade on public stock exchanges. In order to sell Remepy shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Remepy does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Remepy share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Remepy stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Remepy stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Remepy stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Remepy is a private company and has not had an IPO. There is currently no Remepy IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Remepy IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
